New England Journal of Medicine · 1983 · 183 citations · 15 references
MedicinePediatricsPharmacologyNeonatologyPediatric PulmonologyPulmonologyNeonatal PharmacologyNeonatal PhysiologyNeonatal Respiratory DisordersPulmonary HypertensionRespiratory Distress In NewbornsRespiratory Distress SyndromeLeukotriene MediatorsLung ComplianceNeonatal Pulmonary HypertensionNeonatal Respiratory Distress SyndromeNeonatal Respiratory PhysiologyPediatric Pulmonary Hypertension
Persistent pulmonary hypertension of the newborn is a syndrome consisting of severe hypoxemia and pulmonary hypertension that appears within hours of birth. Since certain leukotrienes (C4, D4, and E4) are known to produce some of the features of persistent pulmonary hypertension of the newborn, including pulmonary vasoconstriction, bronchoconstriction, decreased lung compliance, and pulmonary edema, we studied five newborns with the syndrome to determine whether these leukotrienes were present in their airways. We found leukotriene C4 and leukotriene D4 in the lung lavage fluids of all five newborns who had the clinical diagnosis of persistent pulmonary hypertension and who required ventilatory assistance. In contrast, leukotrienes were not demonstrated in a control group of 14 infants requiring ventilatory assistance who did not have the clinical diagnosis of persistent pulmonary hypertension. We conclude that leukotrienes may have a role in persistent pulmonary hypertension of the newborn.
15
Sven‐Erik Dahlén, J Björk, Per Hedqvist et al. · Proceedings of the National Academy of Sciences · 1981 · 1K citations · Full text
Bronchoconstrictor Effects of Leukotriene C in Humans
J. Woodrow Weiss, Jeffrey M. Drazen, N. Anthony Coles et al. · Science · 1982 · 410 citations